标题
Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
作者
关键词
-
出版物
npj Vaccines
Volume 6, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-10-29
DOI
10.1038/s41541-021-00388-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol
- (2021) Helen S. Marshall et al. Human Vaccines & Immunotherapeutics
- VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea
- (2021) Laura M. Reyes Díaz et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy
- (2021) Cecilia Fazio et al. Human Vaccines & Immunotherapeutics
- COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough
- (2021) Rita Rubin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination
- (2021) Federico Martinón-Torres et al. JOURNAL OF INFECTION
- The Neisseria gonorrhoeae Vaccine Candidate NHBA Elicits Antibodies That Are Bactericidal, Opsonophagocytic and That Reduce Gonococcal Adherence to Epithelial Cells
- (2020) Evgeny A. Semchenko et al. Vaccines
- Synergic complement‐mediated bactericidal activity of monoclonal antibodies with distinct specificity
- (2020) Eriberto Noel Natali et al. FASEB JOURNAL
- Methods to evaluate serogroup B meningococcal vaccines: From predictions to real-world evidence
- (2020) Ray Borrow et al. JOURNAL OF INFECTION
- Strain coverage of Bexsero vaccine assessed by whole-genome sequencing over a cohort of invasive meningococci of serogroups B and W isolated in Switzerland
- (2020) Stefano Leo et al. VACCINE
- First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England
- (2020) Shamez N Ladhani et al. CLINICAL INFECTIOUS DISEASES
- Meningococcal Deduced Vaccine Antigen Reactivity (MenDeVAR) Index: a Rapid and Accessible Tool that Exploits Genomic Data in Public Health and Clinical Microbiology Applications
- (2020) Charlene M.C. Rodrigues et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Four-component Meningococcal Serogroup B Vaccine Induces Antibodies With Bactericidal Activity Against Diverse Outbreak Strains in Adolescents
- (2020) Alessia Biolchi et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal
- (2020) Fernanda M. P. Rodrigues et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae
- (2020) Isabelle Leduc et al. PLoS Pathogens
- Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016
- (2019) Jane Rowley et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
- (2019) Vega Masignani et al. Frontiers in Immunology
- Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine
- (2019) Henju Marjuki et al. mBio
- Gonorrhoea
- (2019) Magnus Unemo et al. Nature Reviews Disease Primers
- Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes
- (2018) M. Giuliani et al. Scientific Reports
- Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development
- (2018) A. W. Dretler et al. Human Vaccines & Immunotherapeutics
- The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae
- (2018) Evgeny A Semchenko et al. CLINICAL INFECTIOUS DISEASES
- Meningococcal B vaccine (4CMenB): the journey from research to real world experience
- (2018) Rino Rappuoli et al. Expert Review of Vaccines
- Frequent capsule switching in ‘ultra-virulent’ meningococci – Are we ready for a serogroup B ST-11 complex outbreak?
- (2017) Jay Lucidarme et al. JOURNAL OF INFECTION
- Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study
- (2017) Helen Petousis-Harris et al. LANCET
- Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model
- (2017) Y Liu et al. Mucosal Immunology
- Novel approaches to Neisseria meningitidis vaccine design
- (2017) Myron Christodoulides et al. Pathogens and Disease
- Possible Impact of Wide-scale Vaccination Against Serogroup B Neisseria Meningitidis on Gonorrhea Incidence Rates in One Region of Quebec, Canada
- (2017) Jean Longtin et al. Open Forum Infectious Diseases
- The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection
- (2016) Ray Borrow et al. Expert Review of Vaccines
- Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined
- (2016) Massimiliano Biagini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intractable problems require novel solutions: it's time to get serious about developing a gonorrhoea vaccine
- (2016) Evgeny A Semchenko et al. SEXUALLY TRANSMITTED INFECTIONS
- Meningococcal serogroup B vaccines: Estimating breadth of coverage
- (2016) Robert G. K. Donald et al. Human Vaccines & Immunotherapeutics
- Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets
- (2015) Dennis K.S. Law et al. BMC MICROBIOLOGY
- Neisseria meningitidis: pathogenesis and immunity
- (2015) Mariagrazia Pizza et al. CURRENT OPINION IN MICROBIOLOGY
- Mortality From Sexually Transmitted Diseases in Reproductive-Aged Women: United States, 1999–2010
- (2014) Kara A. McElligott AMERICAN JOURNAL OF PUBLIC HEALTH
- Neisseria meningitidis; clones, carriage, and disease
- (2014) R.C. Read CLINICAL MICROBIOLOGY AND INFECTION
- Progressive Decrease in the Potential Usefulness of Meningococcal Serogroup B Vaccine (4CMenB, Bexsero®) in Gipuzkoa, Northern Spain
- (2014) Emilio Pérez-Trallero et al. PLoS One
- Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
- (2013) Johan Holst et al. Human Vaccines & Immunotherapeutics
- Novel meningococcal 4CMenB vaccine antigens - prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae
- (2012) Ronza Hadad et al. APMIS
- The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens
- (2012) Davide Serruto et al. VACCINE
- Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
- (2012) Eva Hong et al. VACCINE
- Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States
- (2011) Xin Wang et al. VACCINE
- Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen
- (2011) David M. Vu et al. VACCINE
- Review of Meningococcal Group B Vaccines
- (2010) Dan M. Granoff CLINICAL INFECTIOUS DISEASES
- Chlamydia trachomatis infection: host immune responses and potential vaccines
- (2008) L Hafner et al. Mucosal Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More